Standard Biotools: Peers

The FY2025 (Dec) proxy of Standard Biotools names 22 peer companies for pay. Among Standard Biotools and these peers, CEO pay was 5th highest of 13 and total shareholder return was 11th highest of 13.

5th highest of 13in Standard Biotools and its pay peers, FY2025 (Dec) by CEO pay:

$2.4M$23.2M

11th highest of 13in Standard Biotools and its pay peers, FY2025 (Dec) by total shareholder return:

$7$495

Pay peer group, FY2025 (Dec) proxy

Halozyme Therapeutics
Twist Bioscience
Mirum Pharmaceuticals
Adaptive Biotechnologies
Veracyte
CareDx
Castle Biosciences
10x Genomics
Cytek Biosciences
Pacific Biosciences Of California
Orasure Technologies
Cryoport
AzentaNot disclosedNot disclosed
Deciphera Pharmaceuticals, Inc.Not disclosedNot disclosed
Gingko Bioworks Holdings, Inc.Not disclosedNot disclosed
Guardant HealthNot disclosedNot disclosed
Maravai Lifesciences HoldingsNot disclosedNot disclosed
Mesa Laboratories Inc /Co/Not disclosedNot disclosed
NeogenomicsNot disclosedNot disclosed
QuanterixNot disclosedNot disclosed
Surmodics, Inc.Not disclosedNot disclosed
iRhythm Technologies, Inc.Not disclosedNot disclosed
22 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.